Access to innovation: Is there a difference in the use of expensive anticancer drugs between French hospitals?
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2013.11.006
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Gérard de Pouvourville, 2009. "Les hôpitaux français face au paiement prospectif au cas. La mise en œuvre de la tarification à l'activité," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 457-470.
- Joshua Cohen & Laura Faden & Susan Predaris & Brian Young, 2007. "Patient access to pharmaceuticals: an international comparison," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(3), pages 253-266, September.
- Albane Degrassat-Théas & M. Bensadon & C. Rieu & M. Angalakuditi & Claude Le Pen & Pascal Paubel, 2012. "Hospital Reimbursement Price Cap for Cancer Drugs: the French experience in controlling hospital drug expenditures," Post-Print hal-01507735, HAL.
- Albane Degrassat-Théas & M. Bensadon & C. Rieu & M. Angalakuditi & C. Pen & P. Paubel, 2012. "Hospital Reimbursement Price Cap for Cancer Drugs," PharmacoEconomics, Springer, vol. 30(7), pages 565-573, July.
- Cappellaro, Giulia & Ghislandi, Simone & Anessi-Pessina, Eugenio, 2011. "Diffusion of medical technology: The role of financing," Health Policy, Elsevier, vol. 100(1), pages 51-59, April.
- repec:dau:papers:123456789/11666 is not listed on IDEAS
- Nigel Rice & Andrew Jones, 1997. "Multilevel models and health economics," Health Economics, John Wiley & Sons, Ltd., vol. 6(6), pages 561-575, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Rachet-Jacquet, Laurie & Toulemon, Léa & Rochaix, Lise, 2021.
"Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List,"
Health Policy, Elsevier, vol. 125(7), pages 923-929.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," PSE-Ecole d'économie de Paris (Postprint) halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Post-Print halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Institut des Politiques Publiques halshs-03238834, HAL.
- Andrea Gabrio & Catrin Plumpton & Sube Banerjee & Baptiste Leurent, 2022. "Linear mixed models to handle missing at random data in trial‐based economic evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 31(6), pages 1276-1287, June.
- Nicola Pontarollo & Mercy Orellana & Joselin Segovia, 2020.
"The Determinants of Subjective Well-Being in a Developing Country: The Ecuadorian Case,"
Journal of Happiness Studies, Springer, vol. 21(8), pages 3007-3035, December.
- Nicola Pontarollo & Mercy Orellana Bravo & Joselin Segovia Sarmiento, 2017. "The determinants of subjective wellbeing in a developing country: The Ecuadorian case," JRC Research Reports JRC109319, Joint Research Centre.
- Laudicella, Mauro & Olsen, Kim Rose & Street, Andrew, 2010. "Examining cost variation across hospital departments-a two-stage multi-level approach using patient-level data," Social Science & Medicine, Elsevier, vol. 71(10), pages 1872-1881, November.
- Apostolos Tsiachristas† & Ren頇oudriaan & Wim Groot, 2013. "The welfare effects of innovative pharmaceuticals: an international perspective from the Dutch experience," Applied Economics, Taylor & Francis Journals, vol. 45(9), pages 1219-1226, March.
- Zenelabden, Nouran & Dikgang, Johane, 2021. "Satisfaction with water services delivery in South Africa: the effects of social comparison," EfD Discussion Paper 21-7, Environment for Development, University of Gothenburg.
- Richard Grieve & Richard Nixon & Simon G. Thompson & Charles Normand, 2005. "Using multilevel models for assessing the variability of multinational resource use and cost data," Health Economics, John Wiley & Sons, Ltd., vol. 14(2), pages 185-196, February.
- Kollerup, Anna & Wadmann, Sarah & Bek, Toke & Kjellberg, Jakob, 2022. "National clinical guidelines and treatment centralization do not guarantee consistency in healthcare delivery. A mixed-methods study of wet age-related macular degeneration treatment in Denmark," Health Policy, Elsevier, vol. 126(12), pages 1291-1302.
- Mousquès, Julien & Renaud, Thomas & Scemama, Olivier, 2010. "Is the "practice style" hypothesis relevant for general practitioners? An analysis of antibiotics prescription for acute rhinopharyngitis," Social Science & Medicine, Elsevier, vol. 70(8), pages 1176-1184, April.
- Marjon M. Van Der Pol & John A. Cairns, 1998. "The efficient organization of blood donation," Health Economics, John Wiley & Sons, Ltd., vol. 7(5), pages 455-463, August.
- Mangham-Jefferies, Lindsay & Hanson, Kara & Mbacham, Wilfred & Onwujekwe, Obinna & Wiseman, Virginia, 2014. "What determines providers' stated preference for the treatment of uncomplicated malaria?," Social Science & Medicine, Elsevier, vol. 104(C), pages 98-106.
- Fredrik Carlsson & Peter Martinsson, 2001.
"Willingness to pay for reduction in air pollution: a multilevel analysis,"
Environmental Economics and Policy Studies, Springer;Society for Environmental Economics and Policy Studies - SEEPS, vol. 4(1), pages 17-27, March.
- Fredrik Carlsson & Peter Martinsson, 2001. "Willingness to pay for reduction in air pollution: a multilevel analysis," Environmental Economics and Policy Studies, Springer;Society for Environmental Economics and Policy Studies - SEEPS, vol. 4(1), pages 17-27, March.
- Kim Rose Olsen & Andrew Street, 2008. "The analysis of efficiency among a small number of organisations: How inferences can be improved by exploiting patient‐level data," Health Economics, John Wiley & Sons, Ltd., vol. 17(6), pages 671-681, June.
- Marie-Claude Martin, 2008. "Individual and Collective Resources and Health in Morocco," WIDER Working Paper Series RP2008-21, World Institute for Development Economic Research (UNU-WIDER).
- M. Lippi Bruni & L. Nobilio & C. Ugolini, 2007. "Economic Incentives in General Practice: the Impact of Pay for Participation Programs on Diabetes Care," Working Papers 607, Dipartimento Scienze Economiche, Universita' di Bologna.
- Gianluca Fiorentini & Elisa Iezzi & Matteo Lippi Bruni & Cristina Ugolini, 2011.
"Incentives in primary care and their impact on potentially avoidable hospital admissions,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(4), pages 297-309, August.
- G. Fiorentini & E. Iezzi & M. Lippi Bruni & C. Ugolini, 2009. "Incentives In Primary Care and Their Impact on Potentially Avoidable Hospital Admissions," Working Papers 660, Dipartimento Scienze Economiche, Universita' di Bologna.
- Frank Eijkenaar & René C. J. A. van Vliet, 2014. "Performance Profiling in Primary Care," Medical Decision Making, , vol. 34(2), pages 192-205, February.
- Verniers, Isabel & Stremersch, Stefan & Croux, Christophe, 2011. "The global entry of new pharmaceuticals: A joint investigation of launch window and price," International Journal of Research in Marketing, Elsevier, vol. 28(4), pages 295-308.
- Martin Halla & Friedrich G. Schneider, 2005.
"Taxes and Benefits: Two Distinct Options to Cheat on the State?,"
Economics working papers
2005-05, Department of Economics, Johannes Kepler University Linz, Austria.
- Halla, Martin & Schneider, Friedrich, 2008. "Taxes and Benefits: Two Distinct Options to Cheat on the State?," IZA Discussion Papers 3536, Institute of Labor Economics (IZA).
- Lea Toulemon, 2018. "The effect of group purchasing on prices hospitals pay for medicines," Health Economics, John Wiley & Sons, Ltd., vol. 27(9), pages 1380-1393, September.
More about this item
Keywords
Hospitals; Patient access; Innovation; Anticancer drugs;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:116:y:2014:i:2:p:162-169. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.